Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.

Translated title of the contribution: Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.

M.C. Minnema, I. Breitkreutz, J.J. Auwerda, B. van der Holt, F.W. Cremer, A.M.W. van Marion, P.H. Westveer, P. Sonneveld, H. Goldschmidt, H.M. Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPrevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.
Original languageUndefined/Unknown
Pages (from-to)2044-2046
Number of pages3
JournalLeukemia
Volume18
Issue number12
Publication statusPublished - 2004

Cite this